🧪 Hypotheses

combination 0.00

LDLR-Primed LRP1 Transcytosis with pH-Responsive Escape Strategy

🧬 LDLR 🏥 neuropharmacology 📖 15🏛 1

✅ 0.00 ✨ 0.00 💥 0.00

This strategy combines targeted upregulation of LDLR expression in brain endothelial cells with engineered antibodies designed for LRP1-mediated trans...

combination 0.00

LDLR-Mediated Neurosteroid Precursor Delivery Strategy

🧬 LDLR 🏥 neuropharmacology 📖 15🏛 1

✅ 0.00 ✨ 0.00 💥 0.00

The LDLR-Mediated Neurosteroid Precursor Delivery Strategy proposes utilizing the low-density lipoprotein receptor (LDLR) not for antibody transport, ...

combination 0.00

GLUT1-Mediated Carrier-Conjugate Delivery Strategy

🧬 LDLR 🏥 neuropharmacology 📖 15🏛 1

✅ 0.00 ✨ 0.00 💥 0.00

The GLUT1-Mediated Carrier-Conjugate Delivery Strategy proposes that therapeutic antibody delivery to the CNS can be optimized by targeting the glucos...

mechanistic 0.96

GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Clearance

🧬 GRIN2B 🏥 neuroscience 📖 30🏛 4

✅ 0.85 ✨ 0.78 💥 0.82

## Mechanistic Overview...

mechanistic 0.95

Cortico-Striatal Synchrony Restoration via NMDA Modulation

🧬 GRIN2B 🏥 neuroscience 📖 15🏛 3

✅ 0.78 ✨ 0.34 💥 0.80

**Molecular Mechanism and Rationale**...

mechanistic 0.94

Microglial-Mediated Tau Clearance Dysfunction via TREM2 Receptor Impairment

🧬 MAPT 🏥 neuroscience 📖 17🏛 3

✅ 0.77 ✨ 0.56 💥 0.79

**Molecular Mechanism and Rationale**...

mechanistic 0.92

Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming in Neurodegeneration

🧬 NLRP3, CASP1, IL1B, PYCARD 🏥 neurodegeneration 📖 51🏛 1

✅ 0.72 ✨ 0.50 💥 0.00

## Mechanistic Overview...

therapeutic 0.89

APOE-Dependent Autophagy Restoration

🧬 MTOR 🏥 neurodegeneration 📖 56🏛 3

✅ 0.90 ✨ 0.60 💥 0.80

## Mechanistic Overview...

unknown 0.89

Hypothesis 4: Metabolic Coupling via Lactate-Shuttling Collapse

🧬 SLC16A1, SLC16A7, LDHA, PDHA1 🏥 neurodegeneration 📖 21🏛 1

✅ 0.70 ✨ 0.62 💥 0.68

## Mechanistic Overview...

combination 0.89

p38α Inhibitor and PRMT1 Activator Combination to Restore Physiological TDP-43 Phosphorylation-Methylation Balance

🧬 MAPK14/PRMT1 🏥 neurodegeneration 📖 18🏛 1

✅ 0.78 ✨ 0.65 💥 0.82

## Mechanistic Overview...

mechanistic 0.89

SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senescence

🧬 SIRT1 🏥 neurodegeneration 📖 61🏛 3

✅ 0.80 ✨ 0.70 💥 0.76

## Mechanistic Overview...

mechanistic 0.89

TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegeneration

🧬 TREM2 🏥 neurodegeneration 📖 21🏛 3

✅ 0.68 ✨ 0.72 💥 0.82

## Mechanistic Overview...

unknown 0.89

Optimized Temporal Window for Metabolic Boosting Therapy Determines Success of Microglial State Transition Restoration

🧬 IFNG 🏥 neurodegeneration 📖 20🏛 1

✅ 0.50 ✨ 0.75 💥 0.75

## Mechanistic Overview...

unknown 0.89

TREM2-APOE Axis Dissociation for Selective DAM Activation

🧬 TREM2-APOE axis 🏥 neurodegeneration 📖 35🏛 1

✅ 0.35 ✨ 0.78 💥 0.68

## Mechanistic Overview...

therapeutic 0.88

Circadian Glymphatic Entrainment via Targeted Orexin Receptor Modulation

🧬 HCRTR1/HCRTR2 🏥 neurodegeneration 📖 37🏛 2

✅ 0.90 ✨ 0.75 💥 0.80

## Mechanistic Overview...

unknown 0.87

Complement Cascade Inhibition Synaptic Protection

🧬 N/A 🏥 neurodegeneration 📖 50🏛 1

✅ 0.55 ✨ 0.70 💥 0.72

## Mechanistic Overview...

unknown 0.87

Gamma Oscillation Entrainment Enhances lncRNA-9969-Mediated Autophagy Through PV Interneuron-Specific ceRNA Networks

🧬 PVALB, CREB1, lncRNA-9969, neuronal autophagy pathway 🏥 molecular-neurobiology 📖 38🏛 1

✅ 0.55 ✨ 0.70 💥 0.65

## Mechanistic Overview...

combination 0.86

Glymphatic-Mediated Tau Clearance Dysfunction

🧬 MAPT 🏥 neuroscience 📖 31🏛 3

✅ 0.68 ✨ 0.85 💥 0.78

## Mechanistic Overview...

unknown 0.86

TREM2 R47H Variant-Driven Metabolic Dysfunction as the Primary Trigger for Failed DAM Transition

🧬 NAMPT 🏥 neurodegeneration 📖 32🏛 1

✅ 0.50 ✨ 0.65 💥 0.75

## Mechanistic Overview...

combination 0.86

TREM2-Mediated Microglial Dysfunction Disrupts Perivascular Tau Clearance

🧬 TREM2 🏥 neuroscience 📖 28🏛 4

✅ 0.00 ✨ 0.49 💥 0.00

## Mechanistic Overview...

unknown 0.86

H6: Aberrant eIF2α Phosphorylation Creates Stalled Translation State

🧬 EIF2S1, EIF2AK3/PERK, PPP1R15B, EIF2B 🏥 neurodegeneration 📖 50🏛 1

✅ 0.92 ✨ 0.70 💥 0.90

## Mechanistic Overview...

therapeutic 0.85

Senescent Cell ASM-Complement Cascade Intervention

🧬 SMPD1 🏥 neurodegeneration 📖 54🏛 1

✅ 0.68 ✨ 0.78 💥 0.75

## Mechanistic Overview...

mechanistic 0.85

Prime Editing Precision Correction of APOE4 to APOE3 in Microglia

🧬 APOE 🏥 neurodegeneration 📖 28🏛 3

✅ 0.65 ✨ 0.80 💥 0.85

## Mechanistic Overview...

unknown 0.85

TREM2-Deficient Microglia as Drivers of Amyloid Plaque Toxicity in Alzheimer's Disease

🧬 TREM2 🏥 neurodegeneration 📖 39🏛 2

✅ 0.85 ✨ 0.65 💥 0.82

TREM2 loss-of-function variants impair microglial survival, clustering around amyloid plaques, and phagocytic clearance, creating a non-cell-autonomou...

unknown 0.84

TYROBP (DAP12) Conditional Antagonism for Early-Stage Neuroprotection

🧬 TYROBP 🏥 neurodegeneration 📖 36🏛 1

✅ 0.28 ✨ 0.82 💥 0.58

## Mechanistic Overview...

therapeutic 0.84

Neutral Sphingomyelinase-2 Inhibition for Synaptic Protection in Neurodegeneration

🧬 SMPD3 🏥 neurodegeneration 📖 45🏛 1

✅ 0.68 ✨ 0.78 💥 0.75

## Mechanistic Overview...

unknown 0.84

miR-155/Interferon-gamma Feedback Loop as a Reversible Molecular Switch for Protective Microglial State Transition

🧬 MIR155 🏥 neurodegeneration 📖 45🏛 1

✅ 0.35 ✨ 0.80 💥 0.65

## Mechanistic Overview...

unknown 0.84

Hypothesis 7: SST-SST1R/Gamma Entrainment-Enhanced Astrocyte Secretome

🧬 SST, SSTR1, SSTR2 🏥 neurodegeneration 📖 8🏛 1

✅ 0.85 ✨ 0.72 💥 0.82

## Mechanistic Overview...

unknown 0.84

Sequential Iron Chelation (Deferoxamine) and GPX4 Restoration (Sulforaphane) Prevents the Self-Amplifying Iron-Ferroptos

🧬 Labile iron pool (deferoxamine target) and GPX4 (sulforaphane target) 🏥 neurodegeneration 📖 36🏛 1

✅ 0.60 ✨ 0.55 💥 0.70

## Mechanistic Overview...

unknown 0.84

Gamma Oscillation Enhancement Synergy

🧬 N/A 🏥 neurodegeneration 📖 23🏛 1

✅ 0.45 ✨ 0.78 💥 0.65

## Mechanistic Overview...